TCG Crossover Management »

Kodiak Sciences shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Kodiak Sciences (KOD) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Kodiak Sciences

Tip: Access up to 7 years of quarterly data

All positions including Kodiak Sciences held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kodiak Sciences by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.1M 900k 2.35
2024-03-31 $4.7M 900k 5.26
2023-12-31 $815k 268k 3.04

More positions owned by TCG Crossover Management

Cg Oncology Comm (CGON)
Dyne Therapeutics Comm (DYN)
Abivax SA Adrs (ABVX)
Silence Therapeutics Adrs (SLN)
Cogent Biosciences Comm (COGT)
Savara Comm (SVRA)
Madrigal Pharmaceuticals Comm (MDGL)
Edgewise Therapeutics Comm (EWTX)
Keros Therapeutics Comm (KROS)
Mineralys Therapeutics Comm (MLYS)
Ocular Therapeutix Comm (OCUL)
Tyra Biosciences Comm (TYRA)
Kura Oncology Comm (KURA)
Structure Therapeutics Adrs (GPCR)
Centessa Pharmaceuticals Comm (CNTA)

View all positions for TCG Crossover Management

Top funds holding Kodiak Sciences

Baker Bros. Advisors
BlackRock
BlackRock
Acadian Asset Management
Vanguard Group
Silverarc Capital Management
ICONIQ Capital
D. E. Shaw & Co
TCG Crossover Management
State Street Corporation
Geode Capital Management
Newtyn Management
Board of Trustees of The Leland Stanford Junior University
Renaissance Technologies
Jacobs Levy Equity Management

View all funds holding Kodiak Sciences